Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients. 2011

José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
Department of Nephrology - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain. jrodperd@gobiernodecanarias.org

We evaluated the anti-hypertensive and anti-albuminuric effect of the angiotensin receptor blocker telmisartan alone and in combination with torasemide and amlodipine. Patients were hypertensive, both diabetics and non-diabetics with persistent microalbuminuria. Our primary endpoint was a change in microalbuminuria levels, while the secondary endpoints were changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), serum creatinine levels, and glomerular filtration rate.After the 16-week treatment period, the patients significantly reduced microalbuminuria levels (76.4 ± 52.4 μg/min; p < 0.001), SBP (16.4 ± 8.7 mmHg; p < 0.001) and DBP (17.7 ± 5.9 mmHg; p < 0.001). Both diabetics and non-diabetics showed an identical pattern of significance with respect to the whole population. Systolic blood pressure, DBP, and microalbuminuria were significantly reduced as a consequence of therapy, both in diabetics and non-diabetics.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration

Related Publications

José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
July 2010, Journal of hypertension,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
December 2007, British journal of pharmacology,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
September 2003, Journal of the American College of Cardiology,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
January 2005, The Journal of international medical research,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
January 2022, Frontiers in pharmacology,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
January 2010, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
June 2001, Clinical science (London, England : 1979),
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
May 2005, Journal of hypertension,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
January 1999, Journal of the American Society of Nephrology : JASN,
José C Rodríguez-Pérez, and Miguel A García-Bello, and Aránzazu Anabitarte-Prieto, and Osmel Companioni, and Francisco J Nóvoa-Mogollón, and Saturnino Suárez-Ortega, and Celia Plaza-Toledano, and Francisco Rodríguez-Esparragón
July 2010, The Indian journal of medical research,
Copied contents to your clipboard!